drugset / Trial / NCT00467441

VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

NCT00467441 ↗

Phase 2 Completed 60 enrolled Vanda Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and efficacy of VSF-173 compared to placebo in treatment of induced excessive sleepiness.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject VSF-173 Unknown — —

Indications